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KEYWORDS	
	 A	 series	 of	 novel	 thiosemicarbazone	 compounds,	HL1,	 2‐(1‐(2‐phenyl‐hydrazono)‐propan‐2‐
ylidene)hydrazine‐carbothioamide	 (TPHP),	 HL2,	 N‐methyl‐2‐(1‐(2‐phenyl‐hydrazono)‐
propan‐2‐ylidene)hydrazinecarbothioamide	 (MTPHP)	 and,	 HL3,	 N‐phenyl‐2‐(1‐(2‐phenyl‐
hydrazono)‐propan‐2‐ylidene)hydrazinecarbothioamide	 (PTPHP)	and	 their	Ni(II)	 complexes
have	 been	 synthesized	 and	 characterized	 using	 elemental	 analysis,	 magnetic	 susceptibility,
molar	conductance	and	spectral	measurements.	IR	spectra	indicate	that	the	free	ligands	exist
in	 the	 thione	 form	rather	 than	 thiol	 form	 in	 the	solid	 state.	 In	all	 the	 studied	 complexes,	 all
ligands	behave	as	a	tridenate	anion	with	coordination	involving	the	two	azomethine	nitrogens
and	the	thiolate	sulfur	after	deprotonation.	The	magnetic	and	spectral	data	indicates	a	square
planar	 geometry	 for	Ni(II)	 complexes.	 The	 structures	 of	 the	 free	 thiosemicarbazone	 ligands
and	 their	 Ni(II)	 complexes	 have	 been	 modelled	 using	 parameterized	 PM3	 semiempirical
method.	The	free	ligands	and	their	Ni(II)	chelates	have	been	screened	for	their	antimicrobial
activities.	
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1.	Introduction	
	
In	 recent	 years,	 the	 number	 of	 life‐threatening	 infection	
diseases	 caused	 by	 multi‐drug	 resistant	 Gram‐positive	 and	
Gram‐negative	bacteria	has	reached	an	alarming	level	in	many	
countries	 around	 the	world	 [1].	 More	 than	 50	million	 people	
worldwide	 are	 infected	 and	 up	 to	 110,000	 of	 these	 die	 every	
year.	 Antibiotics	 provide	 the	 main	 basis	 for	 the	 therapy	 of	
microbial	(bacterial	and	fungal)	infections.	However,	overuse	of	
antibiotics	has	become	the	major	factor	for	the	emergence	and	
dissemination	of	multi‐drug	resistant	strains	of	several	groups	
of	 microorganisms	 [2].	 Furthermore,	 the	 drugs	 available	 are	
either	too	expensive	or	have	many	undesirable	side	effects	[3].	
Thus,	in	light	of	the	evidence	of	rapid	global	spread	of	resistant	
clinical	isolates,	the	need	to	find	new	antimicrobial	agents	is	of	
paramount	 importance.	 Considerable	 attention	 has	 been	
focused	on	thiosemicarbazone	and	hydrazone	compounds	due	
to	 their	 wide	 biological	 activities	 [4,5].	 Thiosemicarbazones	
have	been	extensively	studied	because	they	have	a	wide	range	
of	 actual	 or	 potential	 medical	 applications	 [6]	 which	 include	
notably	 antiparasital	 [7],	 antibacterial	 [8]	 antitumor	 activities	
[9],	 antiviral	 [10],	 fungicidal	 [11]	 and	 antineoplastic	 [12].	 In	
general,	 thiosemicarbazones	 are	 obtained	 by	 condensation	 of	
the	 corresponding	 thiosemicarbazide	 with	 aldehydes	 or	
ketones.	 Thiosemicarbazones	 (TSCNs)	 exist	 in	 the	 tautomeric	
thione	 (A)	 and	 thiol	 (B)	 forms	 (Scheme	 1).	 Hydrazones	were	
important	 class	 of	 ligands,	 such	 ligands	 have	 interesting	
ligation	 properties	 due	 to	 presence	 of	 several	 coordination	
sites	 [13].	 Hydrazone	 and	 its	 derivatives	 possessing	 anti‐
inflammatory,	 analgesic	 [14],	 antibacterial	 [15]	and	antitumor	
[16]	activities	are	also	reported	in	the	literature.	The	inhibitory	
action	 of	 these	 compounds	 is	 attributed	 to	 their	 chelating	
properties	 to	 different	 metal	 ions	 that	 can	 be	 found	 in	
biological	 systems	 which	 microorganisms	 need	 in	 their	
metabolism	 [17].	 It	 is	 possible	 to	 obtain	 complexes	 that	 are	
more	 efficient	 drugs	 than	 the	 corresponding	 free	 ligands	
[18,19].	 Nickel	 complexes	 with	 thiosemicarbazone	 were	
amongst	the	first	complexes	tested	for	their	anticancer	activity	
[20].	 The	 antimicrobial	 and	 antitumor	 activity	 of	 Ni(II)	
complexes	 have	 been	 noticed	 [15,21,22]	 and	 explored	 in	 the	
last	 few	decades	[23].	With	this	 in	mind,	 it	seems	therefore	of	
considerable	 interest	 to	 synthesize	 and	 characterize	 Ni(II)	
complexes	 with	 the	 novel	 ligands	 containing	 both	 the	
thiosemicarbazone	 and	 hydrazo	 moieties	 (Scheme	 2).	
Additionally,	our	objective	is	also	to	study	the	antibacterial	and	
antifungal	activities	of	the	synthesized	compounds.		
	
2.	Experimental		
	
2.1.	Materials	and	reagents		
	
All	 reagents	 and	 solvents	were	 reagent	 grade.	 NiCl2.6H2O,	
HCl	 and	 KOH	 were	 provided	 by	 BDH	 (British	 Drug	 House).	
Aniline,	 ethyl	 acetoacetate	 and	 sodium	 nitrite	 were	 obtained	
from	 Sigma.	 Thiosemicarbazide,	 4‐(N‐methyl)‐thiosemi‐
carbazide	and	4‐(N‐phenyl)‐thiosemicarbazide	were	purchased	
from	Merck.	All	reagents	are	used	without	further	purification.		
	
2.2.	Synthesis	
	
2.2.1.	Synthesis	of	1‐(phenyl‐hydrazono)‐propan‐2‐one	
(PHP)	
	
1‐(Phenyl‐hydrazono)‐propan‐2‐one	 is	 prepared	 as	
reported	 in	 the	 literature	 [15,24]	 as	 follows:	 in	 a	 4	 L	 beaker	
equipped	with	a	mechanical	stirrer,	65	g	(64	mL,	0.5	moles)	of	
ethyl	 acetoacetate	 was	 added	 to	 35	 g	 (0.53	 moles)	 of	 85%	
potassium	hydroxide	in	1120	mL	of	water.		
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Scheme	1
	
	
	
	
Scheme	2
	
	
The	mixture	is	allowed	to	stand	at	room	temperature	for	24	
h.	Forty‐seven	grams	(48	mL,	0.5	moles)	of	aniline	is	dissolved	
in	 200	 mL	 of	 aqueous	 HCl	 (prepared	 from	 equal	 volumes	 of	
concentrated	 acid	 and	 water)	 in	 a	 2	 L	 beaker.	 The	 beaker	 is	
equipped	with	a	mechanical	stirrer	and	immersed	in	an	ice‐salt	
bath.	After	the	solution	has	cooled	to	0‐5	°C,	36	g.	(0.52	mole)	of	
sodium	nitrite	dissolved	 in	1	L	of	water	 is	added	slowly,	with	
stirring,	 from	 a	 separatory	 funnel.	 The	 tip	 of	 the	 stem	 of	 the	
seperatory	 funnel	dipped	well	below	the	surface	of	 the	 liquid.	
The	 rate	 of	 addition	 is	 adjusted	 to	 maintain	 the	 temperature	
between	 0	 and	 5	 °C.	 A	 drop	 of	 the	 reaction	mixture	 is	 tested	
from	 time	 to	 time	with	 starch‐iodide	 paper	 until	 nitrous	 acid	
persists	in	the	solution	during	a	5	min	interval.	The	solution	of	
potassium	 acetoacetate	 is	 cooled	 to	 0	 °C,	 and	 45	 mL	 of	
concentrated	HCl	 in	150	mL	of	 ice	water	 is	added	slowly	with	
stirring.	 The	 diazonium	 salt	 solution	 is	 then	 added	 over	 a	
period	of	20	min,	and	the	mixture	is	made	basic	by	the	addition	
of	 82	 g	 of	 sodium	 acetate	 dissolved	 in	 300	mL	 of	water.	 The	
temperature	 of	 the	 reaction	mixture	 is	 raised	 slowly	 to	 50	 °C	
and	maintained	at	this	temperature	for	2	h;	the	separated	solid	
is	collected	on	a	filter	and	dried.	The	yield	of	crude	product	 is	
77	 g	 (95%).	 Purification	 can	 be	 effected	 by	 recrystallization	
from	 200	 mL	 of	 toluene.	 The	 purified	 product	 weighs	 66	 g	
(82%);	M.p.:	148‐150	°C.	
	
2.2.2.	Synthesis	of	thiosemicarbazone	compounds		
	
The	general	route	of	synthesis	(Scheme	1)	is	shown	in	the	
following.	Equimolar	amounts	of	 (PHP)	 (0.1620	g,	1	mmol)	 in	
25	 mL	 ethanol	 with	 an	 ethanolic	 solution	 (25	 mL)	 of	
thiosemicarbazide	 (0.0911	 g,	 1	 mmol),	 methyl	 (0.1051	 g,	 1	
mmol)	and	phenyl	(0.1672	g,	1	mmol)	thiosemicarbazides.	The	
reaction	mixture	was	then	refluxed	on	a	hot	plate	for	4‐5	h.	The	
obtained	precipitates	were	 separated	 out,	 filtered	 off,	washed	
with	 diethyl	 ether	 and	 dried	 overnight	 under	 silica	 gel.	 The	
proposed	 chemical	 structures	 of	 the	 prepared	 thiosemi‐
carbazone	 compounds	 are	 in	 a	 good	 agreement	 with	 the	
stoichiometries	 concluded	 from	 their	 analytical	 data	 and	
confirmed	by	the	IR	spectral	data.		
	
2.2.3.	Synthesis	of	complexes	
	
Ni(II)	complexes	were	prepared	as	shown	in	Scheme	2.	The	
appropriate	quantity	of	the	thiosemicarbazone	ligand	(1	mmol)	
was	 dissolved	 in	 absolute	 EtOH	 (30	mL).	 To	 this	 solution	 an	
ethanolic	 solution	 of	 (1	 mmol)	 of	 NiCl2.6H2O	 was	 added	
dropwise	 [1:1	 molar	 ratio,	 M:L].	 The	 reaction	 mixtures	 were	
refluxed	on	a	water	bath	 for	5	h	 and	allowed	 to	 cool	 to	 room	
temperature	overnight.	The	precipitated	complexes	were	then	
filtered	off,	washed	with	petroleum	ether	and	dried	overnight	
in	a	vacuum	desiccator.		
	
2.3.	Molecular	modeling	
	
An	 attempt	 to	 gain	 a	 better	 insight	 on	 the	 molecular	
structure	 of	 these	 synthesized	 thiosemicarbazone	 compounds	
and	 their	 Ni(II)‐complexes,	 geometric	 optimization	 and	
conformation	 analysis	 has	 performed	 using	 semiempirical	
parameterized	PM3	method	as	implemented	in	HyperChem	7.5	
[25].	Convergence	criteria	were	set	to	0.01	kcal/mol.Å	for	PM3	
calculations.	
	
2.4.	Biological	activity	
	
2.4.1.	Antibacterial	and	antifungal	activities	
	
Antimicrobial	 activity	 of	 the	 tested	 samples	 was	
determined	 using	 a	 modified	 Kirby‐Bauer	 disc	 diffusion	
method	 [26].	 Briefly,	 100	 μL	 of	 the	 test	 bacteria/fungi	 were	
grown	 in	 10	mL	 of	 fresh	media	 until	 they	 reached	 a	 count	 of	
approximately	108	cells/mL	or	105	cells/mL	for	fungi	[27].	100	
μL	 of	 microbial	 suspension	 was	 spread	 onto	 agar	 plates	
corresponding	 to	 the	 broth	 in	 which	 they	 were	 maintained.	
Isolated	 colonies	 of	 each	 organism	 that	 might	 be	 playing	 a	
pathogenic	 role	 should	 be	 selected	 from	 primary	 agar	 plates	
and	 tested	 for	 susceptibility	 by	 disc	 diffusion	 method	 of	 the	
National	Committee	for	Clinical	Laboratory	Standards	(NCCLS)	
[28].	 Of	 the	 many	 media	 available,	 NCCLS	 recommends	
Mueller‐Hinton	 agar	 due	 to:	 it	 results	 in	 good	 batch‐to‐batch	
reproducibility.		
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Table	1.	Analytical	and	physical	data	of	Ni(II)‐complexes.	
Compound	 Yield,	%	 Formula	 M.wt,	g	 %	Found	(Calcd.)	
C H N	 S	
TPHP	 72	 C10H13N5S	 51.02	(50.98) 5.53	(5.40) 29.78	(29.70)	 13.62	(13.60)
MTPHP	 67	 C11H15N5S	 53.01	(53.01) 6.02	(5.96) 28.11	(27.80)	 12.85	(12.80)
PTPHP	 63	 C16H17N5S	 61.71	(61.60) 5.46	(5.40) 22.50	(22.49)	 10.29	(10.22)
[Ni(TPHP)Cl].H2O	(1)	 75	 C10H14N5SONiCl 346.46 34.59	(34.67) 4.05	(4.07) 20.18	(20.21)	 9.17	(9.23)
[Ni(MTPHP)Cl]	(2)	 73	 C11H14N5SNiCl 342.47 38.44	(38.58) 4.08	(4.12) 20.41	(20.45)	 9.31	(9.36)
[Ni(PTPHP)Cl]	(3)	 70	 C16H16N5SNiCl 404.54 47.38	(47.50) 3.98	(3.99) 17.28	(17.31)	 7.90	(7.93)
	
	
Disc	diffusion	method	for	filamentous	fungi	tested	by	using	
approved	 standard	method	 (M38‐A)	 developed	 by	 the	NCCLS	
[29]	 for	 evaluating	 the	 susceptibilities	 of	 filamentous	 fungi	 to	
antifungal	 agents.	Disc	 diffusion	method	 for	 yeasts	 developed	
by	 using	 approved	 standard	 method	 (M44‐P)	 by	 the	 NCCLS	
[30].	Plates	inoculated	with	filamentous	fungi	as	as	(Aspergillus	
flavus	RCMB	02568,	Penicillium	italicum	RCMB	03924,	Candida	
albicans	RCMB	05031,	Geotricum	candidum	RCMB	05097)	at	30	
°C	 for	 24‐48	 hours;	 Gram	 (+)	 bacteria	 as	 (Bacillus	 subtillis	
RCMB	010067,	Staphylococcus	aureus	RCMB	010028);	Gram	(‐)	
bacteria	 as	 (Pseudomonas	 aeuroginosa	 RCMB	 010043,	
Escherichia	coli	RCMB	010052),	 they	were	 incubated	at	35‐37	
°C	 for	24‐48	hours	and	 then	 the	diameters	of	 inhibition	zones	
were	 measured	 in	 millimeters	 [31].	 Standard	 discs	 of	
Gentamicin	 (Antibacterial	 agents)	 and	 Amphotericin	 B	
(Antifungal	agent)	served	as	positive	controls	for	antimicrobial	
activity	 but	 filter	 discs	 impregnated	 with	 10	 μL	 of	 solvent	
(DMSO)	 were	 used	 as	 a	 negative	 control.	 The	 agar	 used	 is	
Mueller‐Hinton	 agar	 that	 is	 rigorously	 tested	 for	 composition	
and	pH.	Further	the	depth	of	the	agar	in	the	plate	is	a	factor	to	
be	considered	in	the	disc	diffusion	method.	This	method	is	well	
documented	 and	 standard	 zones	 of	 inhibition	 have	 been	
determined	 for	 susceptible	 and	 resistant	 values.	 Blank	 paper	
disks	(Schleicher	and	Schuell,	Spain)	with	a	diameter	of	8.0	mm	
were	 impregnated	 with	 10	 μL	 of	 tested	 concentration	 of	 the	
stock	 solutions.	When	 a	 filter	 paper	 disc	 impregnated	with	 a	
tested	chemical	is	placed	on	agar,	the	chemical	will	diffuse	from	
the	disc	into	the	agar.	This	diffusion	will	place	the	chemical	 in	
the	agar	only	around	the	disc.	The	solubility	of	the	chemical	and	
its	 molecular	 size	 will	 determine	 the	 size	 of	 the	 area	 of	
chemical	 infiltration	 around	 the	disc.	 If	 an	 organism	 is	placed	
on	the	agar,	it	will	not	grow	in	the	area	around	the	disc	if	it	is	
susceptible	to	the	chemical.	This	area	of	no	growth	around	the	
disc	is	known	as	a	"Zone	of	 inhibition"	or	"Clear	Zone".	For	the	
disc	diffusion,	the	zone	diameters	were	measured	with	slipping	
calipers	of	the	(NCCLS)	[30].	Agar‐based	methods	such	as	E‐test	
and	 disk	 diffusion	 can	 be	 good	 alternatives	 because	 they	 are	
simpler	 and	 faster	 the	 broth‐based	 methods	 [32].	 The	
antibacterial	results	of	the	compounds	were	compared	with	the	
standard	 and	 %	 activity	 index	 for	 the	 compounds	 was	
calculated	by	using	the	formula	as	given	below:	
	
Zone	of	inhibition	by	test	compound	(diameter)
%	Activity	index	=	 x100
Zone	of	inhibition	by	standard	(diameter) 	
(1)	
	
2.4.2.	Minimum	inhibitory	concentration	(MIC)		
	
Compounds	 showing	 promising	 antibacterial/antifungal	
activity	 were	 selected	 for	 minimum	 inhibitory	 concentration	
(MIC)	 studies.	The	MIC	 is	 the	 lowest	concentration	of	 the	 test	
compound,	 which	 inhibits	 the	 visible	 growth	 of	 micro‐
organisms	 after	 incubation,	 and	 the	 minimum	 inhibitory	
concentration	 s	 are	 important	 in	 diagnostic	 laboratories	 to	
confirm	 the	 resistance	 of	 microorganisms	 to	 antimicrobial	
agents.	 The	 synthesized	 compounds	 were	 screened	 against	
bacterial	 and	 fungal	 strains	using	agar	plate	method,	 two	 fold	
serial	dilutions	of	each	test	compound	was	used.	The	culture	of	
each	organism	was	diluted	by	sterile	distilled	water	to	105‐106	
CFU\mL.	 The	 cultures	 were	 incubated	 at	 37	 °C	 for	 24	 hour	
(bacteria)	and	at	28	°C	for	3	to	4	days	(fungi).	DMSO	was	used	
as	negative	control.	
	
2.5.	Instrumentation	
	
The	 microchemical	 analysis	 of	 the	 separated	 solid	
compounds	 was	 carried	 out	 at	 the	 Department	 of	 Chemistry,	
Faculty	 of	 Science,	King	Abdul‐Aziz	University,	 Jeddah,	21589,	
KSA.	The	analyses	were	performed	twice	to	check	the	accuracy	
of	the	analyses	data.	Infrared	spectra	were	recorded	on	a	8001‐
PC	FT‐IR	 Shimadzu	 spectrophotometer	using	KBr	 pellets.	 The	
solid	reflectance	spectra	were	measured	on	a	Schimadzu	3101	
PC	 spectrophotometer.	 The	 room	 temperature	 magnetic	
susceptibility	 measurements	 for	 the	 complexes	 were	
determined	 by	 the	 Gouy	 balance	 using	 Hg[Co(SCN)4]	 as	 a	
calibrant.	
	
3.	Results	and	discussion	
	
The	isolated	thiosemicarbazone	compounds	are	formed	by	
the	 interaction	 of	 PHP	 with	 thiosemicarbazide	 and	 its	
derivatives	 in	 a	 molar	 ratio	 1:1	 under	 reflux	 conditions	
(Scheme	1).	The	formulation	of	these	compounds	based	on	the	
elemental	 analysis	 (Table	 1),	 IR,	 and	 electronic	 spectra.	 The	
solid	compounds	are	air	stable.	These	compounds	are	colored,	
insoluble	 in	 H2O	 and	 other	 common	 organic	 solvents	 like	
methanol	and	ethanol	but	soluble	in	dimethylformamide	(DMF)	
and	 dimethylsulphoxide	 (DMSO).	 Attempts	 to	 obtain	 single	
crystal	 suitable	 for	 X‐ray	 determination	 were	 unsuccessful,	
thus	 molecular	 modeling	 for	 these	 thiosemicarbazone	
compounds	and	 their	Ni(II)‐complexes	were	 investigated.	The	
interaction	 of	 thiosemicarbazone	 ligands	 with	 nickel	 (II)	
chloride	(Scheme	2)	 in	EtOH	in	a	molar	ratio	1:1	under	reflux	
conditions	gave	the	products	formulated	as	[NiLCl].nH2O	where	
L	is	the	deprotonated	ligand.		
	
3.1.	Infrared	spectra	
	
The	 tentative	 assignments	 of	 the	 significant	 IR	 spectral	
bands	 of	 the	 free	 thiosemicarbazone	 compounds	 and	 their	
nickel(II)	complexes	revealing	the	following	features	(Table	2).	
Thiosemicarbazone	 compounds,	 in	 principle	 exhibit	 thione	↔	
thiol	tautomerism	due	to	the	presence	of	a	thiol	amide	‐NH‐C=S	
linkage	 [33].	 The	 absence	 of	 ν(S‐H)	 absorption	 band	 in	 the	
region	 2500‐2600	 cm‐1	 with	 a	 band	 around	 750	 cm‐1	 due	 to	
ν(C=S)	 suggesting	 absence	 of	 any	 thiol	 tautomer	 and	 all	
thiosemicarbazone	 compounds	 remain	 in	 the	 thione	 form	 in	
the	solid	state.	All	of	the	thiomamide	bands	are	shifted	to	some	
degree	but	 the	most	significant	change	 is	 that	observed	 in	 the	
thioamide	 IV	 band,	 which	 contain	 the	 largest	 proportion	 of	
ν(CS)	activity,	 i.e.	 the	C=S	on	coordination	gains	C‐S	character.	
The	negative	shift	of	the	ν(C=S)	band	in	the	complexes	confirm	
the	coordination	via	 the	thiolate	sulfur	[34,35].	The	spectra	of	
the	free	(TPHP)	show	two	bands	at	3265	and	3384	cm‐1,	due	to	
νsym	 and	 νasym	 of	 the	 NH2	 group.	 These	 absorptions	 remain	
unaltered	 in	 the	 metal	 complexes	 confirming	 the	 non‐
involvement	of	 this	 terminal	NH2	group	upon	coordination.	 In	
the	 ligands	 spectra,	 the	 strong	 band	 observed	 in	 the	 range	
1595‐1600	cm‐1	is	assigned	to	ν(C=N)	stretching	vibration	[36].		
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Table	2.	Tentative	assignment	of	the	important	infrared	bands	of	the	synthesized	complexes.		
Compound	 	 νOH	 νNH2	 Thioamide	band	 νN2H	 νN5H	 νC=N	 νN‐N	 νNi‐N	 νNi‐S	 νNi‐Cl	
I	 II III IV
TPHP	 ‐	 3265,	3384	 1500	 1247	 ‐	 750	 3151	 ‐	 1595	 1068	 ‐	 ‐	 ‐	
MTPHP	 ‐	 ‐	 1492	 1255	 3357	 752	 3213	 3357	 1600	 1070	 ‐	 ‐	 ‐	
PTPHP	 ‐	 ‐	 1515	 1257 3346 750 3251 3346 1600 1070	 ‐	 ‐	 ‐
[Ni(TPHP)Cl].H2O	 3510	 3245,	3372	 1498	 1245 ‐ 710 ‐ ‐ 1565 1076	 450	 360 280
[Ni(MTPHP)Cl]	 ‐	 ‐	 1492	 1252 3330 711 ‐ 3330 1562 1079	 445	 360 285
[Ni(PTPHP)Cl]	 ‐	 ‐	 1515	 1254 3328 718 ‐ 3328 1560 1079	 448	 352 288
	
	
Table	3.	Molar	conductance	and	electronic	spectral	data	(cm‐1)	of	the	complexes.	
Compounds	 ΛM	a	 n	→	π* π	→	π* L	→	M d‐d
TPHP	 ‐	 27472	 32787 ‐ ‐	
MTPHP	 ‐	 27548	 32894 ‐ ‐	
PTPHP	 ‐	 26809	 33003 ‐ ‐	
[Ni(TPHP)Cl].H2O	 6.76	 28301 33430 25321
30870	
18815
[Ni(MTPHP)Cl]	 5.23	 28108	 334001	 25603	
30992	
19235	
[Ni(PTPHP)Cl]	 4.01	 27309	 34540	 25445	
31108	
19720	
a	Molar	conductance	measured	for	10‐3	M	DMSO	solution,	Ω‐1	cm2	mol‐1.	
	
	
Table	4.	Antibacterial	activity	of	thiosemicarbazone	compounds.	
Compounds	 Diameter	of	inhibition	zone	(in	mm)	a
Pseudomonas	aeuroginosa	(Gr‐)	
(RCMB	010043)	
Escherichia	Coli	(Gr‐)
(RCMB	010052)	
Bacillus	subtillis	(Gr+)
(RCMB	010067)	
Staphylococcus	aureus (Gr+)
(RCMB	010028)	
TPHP	 NA	 14.0±0.64 19.4±0.64 18.1±0.35	
MTPHP	 NA	 13.4±0.44 18.2±0.32 16.7±0.34	
PTPHP	 NA	 13.6±0.39 18.7±0.67 17.2±0.55	
[Ni(TPHP)Cl].H2O		 NA	 17.3±0.49 19.3±0.24 25.2±0.45	
[Ni(MTPHP)Cl]	 NA	 16.1±0.34 18.2±0.25 23.7±0.49	
[Ni(PTPHP)Cl]	 NA	 15.5±0.25	 17.1±0.12	 22.5±0.24	
Gentamicin	 17.3±0.15	 	22.3±0.18	 27.4±0.18	 32.4±0.10	
a	 Mean	 zone	 of	 inhibition	 in	 mm±standard	 deviation	 beyond	 well	 diameter	 (6	 mm)	 produced	 on	 a	 range	 of	 environmental	 and	 clinically	 pathogenic	
microorganisms	using	(1	mg/mL)	concentration	of	tested	samples.	
	
	
In	the	spectra	of	complexes,	this	band	was	not	observed	at	
the	 same	 frequencies	 and	 the	 same	 intensities.	 They	 shifted	
after	 coordination	 to	 lower	 energies	 by	 ca.	 33‐40	 cm‐1,	
indicating	coordination	via	azomethine	nitrogen	[37].	The	ν(N‐
N)	 of	 the	 thiosemicarbazone	 ligands	 is	 found	 at	 (1068‐1070)	
cm‐1.	 The	 increase	 in	 frequency	of	 this	 band	 in	 the	 spectra	 of	
complexes	is	an	evidence	for	the	enethiolization	of	the	ligands	
and	 the	 coordination	 via	 the	 azomethine	 nitrogen.	 The	
possibility	 of	 α‐nitrogen	 (N2H)	 coordination	 is	 ruled	 out	
because	 of	 considerable	 strain	 [38].	 The	 bands	 observed	 at	
3540‐3545	 cm‐1	 are	 due	 to	 ν(O‐H).	 As	 it	 is	 known	 [34,39,40],	
coordinated	water	 should	exhibit	 frequencies	 at	825,	575	and	
500	cm‐1.	The	absence	of	spectral	bands	in	these	regions	in	the	
spectra	 of	 complexes	 indicates	 that	 the	 water	 molecules	 in	
these	complexes	are	not	coordinated	but	are	present	as	lattice	
water.	The	coordination	positions	of	the	thiosemicarbazones	in	
the	 Ni(II)	 complexes	 are	 confirmed	 by	 assigning	 the	 strong	
bands	 observed	 in	 the	 far	 IR	 spectra	 of	 the	 complexes.	 The	
bands	observed	at	(445‐450)	and	(352‐360)	cm‐1	are	assigned	
to	 ν(Ni‐N)	 [41]	 and	 ν(Ni‐S)	 as	 suggested	 by	 Lever	 [42]	
respectively.	 In	 the	 literature,	 the	 bands	 appearing	 between	
160	and	300	cm‐1	are	allotted	to	the	vibration	of	the	M‐X	bonds	
where	M	=	metal	and	X	=	Cl	or	Br	[37,43].	In	our	case	the	ν(Ni‐
Cl)	 frequencies	 appearing	 between	 280‐288	 cm‐1	 are	 in	 good	
agreement	with	the	reported	values	in	the	literature.	Based	on	
the	 above	 spectral	 evidences,	 it	 is	 confirmed	 that	 the	
thiosemicarbazone	 ligands	 lost	 the	N2	proton	and	coordinated	
to	the	Ni(II)	ion	as	mononegative	tridentate	anion,	coordinating	
via	the	two	azomethine	nitrogen	atoms	and	the	thiolate	sulfur	
atom	after	deprotonation.		
	
3.2.	Conductivity	measurements	
	
Conductivity	measurements	in	non‐aqueous	solutions	have	
frequently	 been	 used	 in	 structural	 studies	 of	 metal	 chelates	
within	the	limits	of	their	solubility.	These	measurements	were	
provided	 a	method	 for	 testing	 the	 degree	 of	 ionization	 of	 the	
complexes,	the	molar	ions	that	a	complex	liberates	in	solution,	
the	 higher	 will	 be	 its	molar	 conductivity	 and	 vice	 versa.	 The	
non‐ionized	 complexes	 have	 negligible	 value	 of	 molar	
conductance.	 It	 is	 clear	 from	 the	 conductivity	 data	 (Table	 3)	
that	 the	 complexes	 present	 seem	 to	 be	 nonelectrolytes	 (4.01‐
6.76	Ω‐1.cm2.mol‐1).	Also	the	molar	conductance	values	indicate	
that	 the	 anions	 were	 existed	 inside	 the	 coordination	 sphere	
which	was	also	confirmed	from	the	chemical	analysis	and	also	
Cl−	ion	is	not	precipitated	by	addition	of	AgNO3	solution.		
	
3.3.	Electronic	spectra		
	
The	 probable	 assignments	 for	 the	 bands	 in	 the	 region	
26809‐27548	and	33003‐32787	cm‐1	are	due	to	the	n	→	π*	and	
π	 →	 π*	 transitions	 of	 thiosemicarbazone	 compounds,	
respectively.	 Always	 n	 →	 π*	 transitions	 occurs	 at	 a	 lower	
energy	 than	 π	 →	 π*	 transitions	 [44].	 In	 the	 spectra	 of	 Ni(II)	
complexes	the	bands	observed	in	the	region	25321‐25603	cm‐1	
are	assigned	to	S	→	Ni	charge‐transfer	band	[45].	The	bands	in	
the	 range	 30870‐31108	 cm‐1	 observed	 in	 the	 spectra	 of	 all	
Ni(II)	 complexes	 are	 assigned	 as	 Cl	 →	 Ni	 charge‐transfer	
transitions	 [46].	 The	 shift	 of	 the	 π	→	 π*	 bands	 to	 the	 longer	
wavelength	 region	 is	 the	 result	 of	 the	 C=S	 bond	 being	
weakened	 and	 conjugation	 system	 being	 enhanced	 after	 the	
formation	 of	 the	 complex	 [47].	 The	 electronic	 spectra	 of	 the	
nickel(II)	 complexes	 (Table	 4)	 showed	 an	 absorption	 band	 in	
the	 range	 18815‐19720	 cm−1	which	 is	 assigned	 to	 the	 square	
planar	1A1g	→	1A2g	transition	[48].	These	d‐d	bands	are	typical	of	
square	 planar	 Ni(II)	 complexes	 [49].	 Absence	 of	 bands	 below	
10000	 cm‐1	 confirms	 square	 planar	 nature	 of	 the	 complex,	
consistent	 with	 low	 spin	 and	 diamagnetic	 (µeff	 =	 0.00	 B.M.)	
nature	[50].	
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Table	5.	Antifungal	activity	of	thiosemicarbazone	compounds.	
Compounds	 Diameter	of	inhibition	zone	(in	mm)	a	
Aspergillus	flavus	
(RCMB	02568)	
Penicillium	italicum
(RCMB	03924)
Candida	albicans
(RCMB	05031)
Geotricum	candidum
(RCMB	05097)	
TPHP	 15.6±0.58	 16.4±0.44	 NA 18.7±0.64	
MTPHP	 13.8±0.58	 14.9±0.64 NA 16.7±0.72	
PTPHP	 14.6±0.52	 15.2±0.58 NA 16.9±0.45	
[Ni(TPHP)Cl].H2O		 17.5±0.39 16.7±0.24	 NA 21.5±0.42	
[Ni(MTPHP)Cl]	 16.6±0.24	 14.7±0.50 NA 19.1±0.60	
[Ni(PTPHP)Cl]	 15.2±	0.68	 13.9±0.56 NA 18.1±0.39	
Amphotericin	(B)	 23.7±0.10	 21.9±0.12	 19.8±0.20	 28.7±0.22	
a	 Mean	 zone	 of	 inhibition	 in	 mm±standard	 deviation	 beyond	 well	 diameter	 (6	 mm)	 produced	 on	 a	 range	 of	 environmental	 and	 clinically	 pathogenic	
microorganisms	using	(1	mg/mL)	concentration	of	tested	samples.	
	
	
Table	6.	Antibacterial	activity	as	MICs	and	activity	index	of	thiosemicarbazone	compounds.	
Compounds	 Pseudomonas	aeuroginosa	(Gr‐)	
(RCMB	010043)	
Escherichia	coli	(Gr‐)
(RCMB	010052)	
Bacillus	subtillis	(Gr+)
(RCMB	010067)	
Staphylococcus	aureus	(Gr+)	
(RCMB	010028)	
MIC	a		 Activity	index	 MIC	a Activity	index MICa Activity	index MIC	a		 Activity	index
TPHP	 NA	 NA	 >100 63 15.63 71 31.25	 56	
MTPHP	 NA	 NA	 >100 60 31.25 66 62.50	 51	
PTPHP	 NA	 NA	 >100	 61	 31.25	 68	 31.25	 53	
[Ni(TPHP)Cl].H2O		 NA	 NA	 3.90	 78	 15.63	 70	 7.25	 87	
[Ni(MTPHP)Cl]	 NA	 NA	 25.97	 72	 25.97	 67	 15.63	 73	
[Ni(PTPHP)Cl]	 NA	 NA	 31.25 70 31.25 62 31.25	 69	
Gentamicin	 31.25	 ‐	 1.95 ‐ 0.007 ‐ 0.12	 ‐	
	a	Antibacterial	activity	as	MICs	(μg/mL)	of	tested	samples	against	tested	microorganisms.	
	
	
Table	7.	Antifungal	activity	as	MICs	and	activity	index	of	thiosemicarbazone	compounds.	
Compounds	 Diameter	of	inhibition	zone	(in mm)a
Aspergillus	fumigatus	
(RCMB	02568)	
Pencicillium	italicum
(RCMB	03924)	
Candida	albicans
(RCMB	05031)	
Geotricum	candidum
(RCMB	05097)	
MIC	a		 Activity	index	 MIC	a		 Activity	index	 MIC	a		 Activity	index	 MIC	a		 Activity	index	
TPHP	 62.50	 54	 31.25 75 NA NA 15.63	 65	
MTPHP	 >100	 48	 62.50 68 NA NA 31.25	 58	
PTPHP	 >100	 51	 62.50 69 NA NA 31.25	 59	
[Ni(TPHP)Cl].H2O		 15.63	 74	 25.97	 76	 NA	 NA	 7.81	 75	
[Ni(MTPHP)Cl]	 31.25	 70	 31.25	 69	 NA	 NA	 15.63	 67	
[Ni(PTPHP)Cl]	 62.50	 64	 62.50	 65	 NA	 NA	 31.25	 63	
Amphotericin	(B)	 1.95	 ‐	 3.9	 ‐	 7.81	 	 0.06	 ‐	
	a	Antifungal	activity	as	MICs	(μg/mL)	of	tested	samples	against	tested	microorganisms.	
	
	
3.4.	Antimicrobial	activity	
	
To	 assess	 the	 biological	 potential	 of	 the	 synthesized	
compounds,	 the	 thiosemicarbazone	 ligands	 and	 their	 metal	
complexes	were	tested	against	different	species	of	bacteria	and	
fungi.	In	testing	the	antimicrobial	activity	of	these	compounds,	
we	used	more	than	one	test	organism	to	increase	the	chance	of	
detecting	 antibiotic	 principles	 in	 tested	 materials.	 The	
organisms	 used	 in	 the	 present	 investigations	 included	 two	
Gram	positive	(Staphylococcus	aureus	and	Bacillus	subtillis)	and	
two	Gram	negative	(Pseudomonas	aeruguinosa	and	Escherichia	
coli).	 The	 diffusion	 agar	 technique	 was	 used	 to	 evaluate	 the	
antibacterial	 activity	 of	 the	 synthesized	 mixed	 ligand	
complexes	 [51‐54].	The	medium	used	 for	 growing	 the	 culture	
was	nutrient	agar.	The	results	of	the	antibacterial	activity	of	the	
synthesized	compounds	are	recorded	in	Tables	4‐7.	Metal	ions	
are	 adsorbed	 on	 the	 cell	 walls	 of	 the	 microorganisms,	
disturbing	 the	 respiration	 processes	 of	 the	 cells	 and	 thus	
blocking	 the	 protein	 synthesis	 that	 is	 required	 for	 further	
growth	of	the	organisms.	Hence,	metal	ions	are	essential	for	the	
growth‐inhibitory	 effects	 [55].	 The	 synthesized	 compounds	
were	 found	 to	be	more	 toxic	 compared	with	 their	parent	 free	
ligands	 against	 the	 same	 micro‐organism	 and	 under	 the	
identical	experimental	conditions.	
According	 to	 Overtone’s	 concept	 of	 cell	 permeability,	 the	
lipid	membrane	 that	 surrounds	 the	 cell	 favors	 the	 passage	 of	
only	 lipid‐soluble	 materials,	 so	 lipophilicity	 is	 an	 important	
factor	 controlling	 the	 antifungal	 activity.	 Upon	 chelating,	 the	
polarity	of	the	metal	 ion	will	be	reduced	due	to	the	overlap	of	
the	ligand	orbitals	and	partial	sharing	of	the	positive	charge	of	
the	metal	 ion	with	donor	groups.	 In	addition,	chelation	allows	
for	the	delocalization	of	π‐electrons	over	the	entire	chelate	ring	
and	enhances	the	lipophilicity	of	the	complexes.	This	increased	
lipophilicity	 facilitates	 the	 penetration	 of	 the	 complexes	 into	
lipid	 membranes,	 further	 restricting	 proliferation	 of	 the	
microorganisms.	The	variation	 in	the	effectiveness	of	different	
compounds	against	different	organisms	depends	either	on	the	
impermeability	 of	 the	microbial	 cells	 or	 on	 differences	 in	 the	
ribosomes	of	the	cells	[56].	All	of	the	metal	complexes	possess	
higher	antifungal	activity	than	the	ligand	[57,58].	Although	the	
exact	 biochemical	 mechanism	 is	 not	 completely	 understood,	
the	 mode	 of	 action	 of	 antimicrobials	 may	 involve	 various	
targets	 in	 the	 microorganisms.	 These	 targets	 include	 the	
following.		
(i) The	 higher	 activity	 of	 the	 metal	 complexes	 may	 be	
due	to	the	different	properties	of	the	metal	ions	upon	
chelation.	 The	 polarity	 of	 the	 metal	 ions	 will	 be	
reduced	due	to	the	overlap	of	the	ligand	orbitals	and	
partial	sharing	of	the	positive	charge	of	the	metal	ion	
with	 donor	 groups.	 Thus,	 chelation	 enhances	 the	
penetration	 of	 the	 complexes	 into	 lipid	 membranes	
and	 the	 blockage	 of	 metal	 binding	 sites	 in	 the	
enzymes	of	the	microorganisms	[59].		
(ii) Tweedy’s	 chelation	 theory	 predicts	 that	 chelation	
reduces	 the	 polarity	 of	 the	 metal	 atom	 mainly	
because	of	partial	sharing	of	 its	positive	charge	with	
donor	 groups	 and	 possible	 electron	 delocalization	
over	the	entire	ring.	This	consequently	 increases	the	
lipophilic	 character	 of	 the	 chelates,	 favoring	 their	
permeation	 through	 the	 lipid	 layers	 of	 the	 bacterial	
membrane	[60].		
(iii) Interference	 with	 the	 synthesis	 of	 cellular	 walls,	
causing	 damage	 that	 can	 lead	 to	 altered	 cell	
permeability	 characteristics	 or	 disorganized	
lipoprotein	arrangements,	ultimately	resulting	in	cell	
death.		
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Table	8.	Some	energetic	properties	of	thiosemicarbazone	compounds	calculated	by	PM3	method.	
Ligand	 Total	energy		
(kcal/mol)	
Binding	
energy	(kcal/mol)	
Electronic	energy	
(kcal/mol)	
Dipole	moment		
(Debye)	
HOMO	(eV)	 LUMO	(eV)	
TPHP	 ‐54861.71	 ‐2887.45	 ‐333133.43 4.81 ‐8.66	 ‐1.05
MTPHP	 ‐54869.01	 ‐2894.00	 ‐339543.84 6.14 ‐8.58	 ‐0.97
PhTPHP	 ‐72667.78	 ‐4097.17	 ‐510622.23 5.17 ‐8.58	 ‐1.13
[Ni(TPHP)Cl].H2O		 ‐85886.52	 ‐3147.44	 ‐499165.10 5.26 ‐8.42	 ‐1.41
[Ni(MTPHP)Cl]	 ‐89303.08	 ‐3395.96	 ‐539051.05	 5.53	 ‐8.37	 ‐1.40	
[Ni(PTPHP)Cl]	 ‐103685.35	 ‐4349.51	 ‐701336.87	 5.77	 ‐8.40	 ‐1.49	
	
	
(iv) Deactivation	 of	 various	 cellular	 enzymes	 that	 play	 a	
vital	 role	 in	 the	 metabolic	 pathways	 of	 these	
microorganisms.		
(v) Denaturation	 of	 one	 or	 more	 cellular	 proteins,	
causing	the	normal	cellular	processes	to	be	impaired.		
(vi) Formation	 of	 a	 hydrogen	 bond	 through	 the	
azomethine	group	with	 the	active	 centers	of	various	
cellular	 constituents,	 resulting	 in	 interference	 with	
normal	cellular	processes	[61].		
The	 mode	 of	 action	 of	 the	 compounds	 may	 involve	
formation	 of	 a	 hydrogen	 bond	 through	 the	 azomethine	 group	
(>C=N‐)	with	the	active	centers	of	various	cellular	constituents,	
resulting	 in	 interference	 with	 normal	 cellular	 processes	
[62,63].	The	tested	complexes	were	more	active	against	Gram‐
positive	than	Gram‐negative	bacteria	[34],	it	may	be	concluded	
that	the	antibacterial	activity	of	the	compounds	is	related	to	cell	
wall	structure	of	the	bacteria.	It	is	possible	because	the	cell	wall	
is	essential	to	the	survival	of	bacteria	and	some	antibiotics	are	
able	 to	 kill	 bacteria	 by	 inhibiting	 a	 step	 in	 the	 synthesis	 of	
peptidoglycan.	Gram‐positive	bacteria	possess	a	thick	cell	wall	
containing	many	layers	of	peptidoglycan	and	teichoic	acids,	but	
in	 contrast,	 Gram	negative	 bacteria	 have	 a	 relatively	 thin	 cell	
wall	consisting	of	a	few	layers	of	peptidoglycan	surrounded	by	
a	 second	 lipid	 membrane	 containing	 lipopolysaccharides	 and	
lipoproteins.	 These	 differences	 in	 cell	 wall	 structure	 can	
produce	 differences	 in	 antibacterial	 susceptibility	 and	 some	
antibiotics	 can	 kill	 only	 Gram‐positive	 bacteria	 and	 is	
ineffective	against	Gram‐negative	pathogens	[64,65].	It	is	worth	
noting	 that	 the	 comparison	 of	 antibacterial	 activity	 of	 the	
compounds	 against	 the	 selected	 types	 of	 bacteria	 (Figure	 1)	
indicates	 that	TPHP		MTPHP		PTPHP.	Thus,	 the	presence	of	
substituents	at	position	N(4)	of	 the	thiosemicarbazone	moiety	
affects	 the	 biological	 activity.	 The	 activity	 index	 of	 the	
synthesized	 compounds	 was	 calculated	 against	 the	 different	
selected	types	of	bacteria	and	it	was	found	that	Ni(II)	complex	
have	 the	 highest	 activity	 index	 against	 Bacillus	 subtillis.	 The	
synthesized	 thiosemicarbazone	 compounds	 and	 their	
complexes	 are	 inactive	 against	 Candida	 albicans.	 The	 MIC	
values	 for	 Ni‐TPHP	 complex	 versus	 Geotricum	 candidum	 and	
Escherichia	 coli	 are	 7.81	 and	 3.90	 μg/mL	 respectively.	 The	
antifungal	activity	was	given	in	Figure	2.	
	
	
	
Figure	1.	Antibacterial	activity	of	Ni(II)‐complexes.
	
	
3.5.	Molecular	modelling	
	
In	 the	 absence	 of	 a	 crystal	 structure,	 to	 obtain	 the	
molecular	 conformation	 of	 a	 compound,	 energy	minimization	
studies	were	carried	out	on	the	basis	of	the	semi‐empirical	PM3	
level	 provided	 by	 HyperChem	 7.5	 software.	 The	 calculated	
dipole	moment,	total	energy	(ET),	binding	energy	(EB),	isolated	
atomic	 energy	 (EIA),	 electronic	 energy	 (EE)	 and	 core‐core	
interaction	 (IC‐C)	 after	 geometrical	 optimization	 of	 the	
structures	of	complexes	were	given	in	Table	8.		
	
	
	
Figure	2.	Antifungal	activity	of	Ni(II)‐complexes.
	
3.5.1.	Bond	length	and	bond	angle	calculations	
	
The	 thiosemicarbazone	 ligands	 might	 exhibits	 two	
tautomeric,	 thione	 and	 thiol,	 forms.	 It	 behaves	 as	 a	 tridentate	
ligand	 with	 ONS	 coordination	 sites.	 The	 ligand	 bond	 lengths	
and	 bond	 angles	 of	 Ni‐TPHP	 as	 a	 representative	 example	 of	
thiosemicarbazone	complexes	are	given	 in	Table	9.	A	drawing	
of	 Ni(II)	 complexes	 with	 the	 atomic	 numbering	 scheme	 is	
shown	 in	 Figures	 3‐5	while	 selected	 bond	 lengths	 and	 angles	
are	given	in	Table	10.	The	coordination	results	 in	the	changes	
of	bond	lengths	and	angles	of	the	thiosemicarbazone	moiety,	as	
expected.	The	C‐S	bond	length	increases	from	1.63(3)	Å	in	the	
free	 TPHP	 ligand	 to	 1.74	 Å	 in	 Ni‐TPHP	 complex.	 Similarly	 N‐
C(S)	bond	suffers	a	significant	decrease	from	1.43	Å	seen	in	the	
free	TPHP	ligand	to	1.37	Å	in	Ni‐TPHP	complex.	These	changes	
indicate	 the	 coordination	 of	 the	 deprotonated	 sulfur	 after	
enethiolization.	 This	 means	 that,	 C‐S	 distances	 (Table	 10)	
which	are	in	the	range	of	single	bond	character	being	some	of	
the	 largest	 found	 for	 thiosemicarbazone	 complexes	 (typical	
bond	 lengths	 being	 C(sp2)‐S	 1.706	 Å	 in	 (MeS)2C=C(SMe)2	 and	
C=S	 1.630	 Å	 in	 naphthylphenylthioketone)	 [63,66].	 This	 also	
confirms	the	IR	and	spectral	data	which	assumed	that	the	C=S	
on	 coordination	 gains	 C‐S	 character.	 Similar	 results	 are	
observed	 for	 both	 MTPHP	 and	 PTPHP	 thiosemicarbazone	
ligands	and	their	complexes	(Table	10).	The	other	bond	lengths	
and	angles	also	suffer	some	changes,	but	not	significantly.	The	
bond	 angles	 around	 nickel	 are	 between	 87‐92°.	 The	 bond	
angles	around	the	Ni(II)	center	(~90°)	prove	that	the	geometric	
is	square	planar	as	proposed	by	the	different	 tools	of	analysis	
mentioned	 previously.	 Finally,	 from	 the	 interpretation	 of	
elemental	 analysis,	 magnetic	 susceptibility	 measurements	 at	
room	 temperature,	 conductivity	 measurements,	 spectral	 data	
and	 QM	 calculations,	 it	 is	 possible	 to	 draw	 up	 the	 tentative	
structures	of	the	metal	complexes.		
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Table	9.	Bond	distances	and	angles	for	Ni‐TPHP.	
Atoms	 Bond	distances	(Å)	 Atoms	 Angle	(o)	 Atoms	 Angle	(o)	
Ni(17)‐Cl(18)	 2.224	 Cl(18)‐Ni(17)‐S(15) 87.787 H(24)‐N(7)‐N(8)	 106.077
C(16)‐H(30)	 1.099	 Cl(18)‐Ni(17)‐N(11) 178.407 H(24)‐N(7)‐C(5)	 118.001
C(16)‐H(29)	 1.098	 Cl(18)‐Ni(17)‐N(8)	 92.496	 N(8)‐N(7)‐C(5)	 122.158	
C(16)‐H(28)	 1.099	 S(15)‐Ni(17)‐N(11)	 92.409	 H(23)‐C(6)‐C(5)	 121.304	
S(15)‐Ni(17)	 2.201	 S(15)‐Ni(17)‐N(8)	 179.610	 H(23)‐C(6)‐C(1)	 119.137	
N(14)‐H(27)	 0.989	 N(11)‐Ni(17)‐N(8)	 87.316	 C(5)‐C(6)‐C(1)	 119.559	
N(14)‐H(26)	 0.990	 H(30)‐C(16)‐H(29) 107.659 N(7)‐C(5)‐C(6)	 122.535
C(13)‐S(15)	 1.749	 H(30)‐C(16)‐H(28) 107.526 N(7)‐C(5)‐C(4)	 117.236
C(13)‐N(14)	 1.352	 H(30)‐C(16)‐C(10) 110.454 C(6)‐C(5)‐C(4)	 120.082
N(12)‐C(13)	 1.379	 H(29)‐C(16)‐H(28) 107.661 H(22)‐C(4)‐C(5)	 120.847
N(11)‐Ni(17)	 1.818	 H(29)‐C(16)‐C(10) 113.065 H(22)‐C(4)‐C(3)	 119.551
N(11)‐N(12)	 1.349	 H(28)‐C(16)‐C(10) 110.268 C(5)‐C(4)‐C(3)	 119.602
C(10)‐C(16)	 1.478	 Ni(17)‐S(15)‐C(13) 90.215 H(21)‐C(3)‐C(4)	 119.677
C(10)‐N(11)	 1.323	 H(27)‐N(14)‐H(26)	 118.227	 H(21)‐C(3)‐C(2)	 119.940	
C(9)‐H(25)	 1.102	 H(27)‐N(14)‐C(13)	 119.366	 C(4)‐C(3)‐C(2)	 120.383	
C(9)‐C(10)	 1.470	 H(26)‐N(14)‐C(13) 122.380 H(20)‐C(2)‐C(3)	 120.031
N(8)‐Ni(17)	 1.837	 S(15)‐C(13)‐N(14)	 123.742	 H(20)‐C(2)‐C(1)	 120.057	
N(8)‐C(9)	 1.315	 S(15)‐C(13)‐N(12) 124.195 C(3)‐C(2)‐C(1)	 119.912
N(7)‐H(24)	 1.096	 N(14)‐C(13)‐N(12) 112.064 H(19)‐C(1)‐C(6)	 119.581
N(7)‐N(8)	 1.360	 C(13)‐N(12)‐N(11) 113.748 H(19)‐C(1)‐C(2)	 119.960
C(6)‐H(23)	 1.100	 Ni(17)‐N(11)‐N(12) 119.419 C(6)‐C(1)‐C(2)	 120.459
C(5)‐N(7)	 1.446	 Ni(17)‐N(11)‐C(10) 112.905 	
C(5)‐C(6)	 1.399	 N(12)‐N(11)‐C(10) 127.649 	
C(4)‐H(22)	 1.098	 C(16)‐C(10)‐N(11)	 127.228	 	 	
C(4)‐C(5)	 1.402	 C(16)‐C(10)‐C(9) 119.237 	
C(3)‐H(21)	 1.095	 N(11)‐C(10)‐C(9)	 113.535	 	 	
C(3)‐C(4)	 1.389	 H(25)‐C(9)‐C(10)	 120.713	 	 	
C(2)‐H(20)	 1.095	 H(25)‐C(9)‐N(8)	 125.777	 	 	
C(2)‐C(3)	 1.392	 C(10)‐C(9)‐N(8) 113.507 	
C(1)‐H(19)	 1.095	 Ni(17)‐N(8)‐C(9) 112.649 	
C(1)‐C(6)	 1.390	 Ni(17)‐N(8)‐N(7) 115.307 	
C(1)‐C(2)	 1.390	 C(9)‐N(8)‐N(7) 131.872 	
	
	
Table	10.	Comparison	of	bond	length	(Å)	and	angles	(o)	for	free	thiosemicarbazone	ligands	and	their	Ni(II)‐complexes.	
	 TPHP	 [Ni(TPHP)Cl].H2O		 MTPHP	 [Ni(MTPHP)Cl]	 PTPHP	 [Ni(PTPHP)Cl]	
Bond	length	
C‐S	 1.631	 1.741	 1.631 1.730 1.658 1.761	
N‐C(S)	 1.437	 1.371	 1.437 1.383 1.439 1.371	
Ni‐S	 ‐	 2.202	 ‐ 2.192 ‐ 2.199	
Ni‐Cl	 ‐	 2.221	 ‐	 2.228	 ‐	 2.224	
Ni‐N	(12)	 ‐	 1.812	 ‐	 1.830	 ‐	 1.818	
Ni‐N	(8)	 ‐	 1.831	 ‐ 1.816 ‐ 1.836	
Bond	angle	
N‐Ni‐N	 ‐	 87.31	 ‐	 88.05	 ‐	 87.41	
N‐Ni‐S	 ‐	 92.40	 ‐ 90.65 ‐ 91.85	
N‐Ni‐Cl	 ‐	 92.49	 ‐ 92.30 ‐ 92.54	
Cl‐Ni‐S	 ‐	 87.78	 ‐ 88.99 ‐ 88.19	
	
	
	
	
	
Figure	3.	The	molecular	 structure	of	 [Ni(TPHP)Cl]	 (1)	along	with	 the	atom	
numbering	scheme.	
	
3.5.2.	Molecular	parameters	
	
Quantum	 chemical	 parameters	 of	 organic	 compounds	 are	
obtained	 from	 calculations,	 such	 as	 the	 energy	 of	 the	 highest	
occupied	 molecular	 orbital,	 EHOMO,	 energy	 of	 the	 lowest	
unoccupied	 molecular	 orbital,	 ELUMO.	 Additional	 parameters,	
such	 as	 separation	 energies	 (ΔE),	 absolute	 electronegativitiy	
(χ),	 chemical	 potentials	 (Pi),	 absolute	 hardness	 (η),	 absolute	
softness	(σ),	global	electrophilicity	(ω)	[67‐71],	global	softness	
(S)	 and	 additional	 electronic	 charge	 (ΔNmax)	 have	 been	
calculated	 [72].	 The	 concepts	 of	 the	 parameters	 χ	 and	 Pi	 are	
related	 to	 each	 other.	 The	 inverse	 of	 the	 global	 hardness	 is	
designated	 as	 the	 softness	 σ	 [73].	 From	 the	 obtained	 data	
(Table	11)	we	can	deduced	that:		
a) Absolute	 hardness	 (η)	 and	 softness	 (σ)	 are	 important	
properties	 to	 measure	 the	 molecular	 stability	 and	
reactivity.	A	hard	molecule	has	a	large	energy	gap	and	a	
soft	molecule	has	a	small	energy	gap.	Soft	molecules	are	
more	reactive	than	hard	ones	because	they	could	easily	
offer	 electrons	 to	 an	acceptor.	 In	 a	 complex	 formation	
system,	the	ligand	acts	as	a	Lewis	base	while	the	metal	
ion	 acts	 as	 a	 Lewis	 acid.	Metal	 ions	 are	 soft	 acids	 and	
thus	 soft	 base	 ligands	 are	 most	 effective	 for	 complex	
formation.	Accordingly,	it	is	concluded	that	TPHP,	with	
a	proper	σ	value	has	a	good	tendency	to	chelate	metal	
ions	 effectively	 [74].	 This	 is	 also	 confirmed	 from	 the	
calculated	chemical	potential	Pi	values.	
b) The	 reactivity	 index	 measures	 the	 stabilization	 in	
energy	 when	 the	 system	 acquires	 an	 additional	
electronic	 charge	 (ΔNmax)	 from	 the	 environment.	 ,	 The	
electrophilicity	 index	 is	 positive	 quantity	 and	 the	
direction	 of	 the	 charge	 transfer	 is	 completely	
determined	by	the	electronic	chemical	potential	(Pi)	of	
the	molecule	because	an	electrophile	is	a	chemical		
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Table	11.	The	calculated	quantum	chemical	parameters	of	the	ligands	and	their	Ni(II)	complexes.	
Compound	 HOMO	(eV)	 LUMO	(eV)	 χ	 η	 σ	 Pi	 ΔE	 ω	 ΔNmax	
TPHP(Thione)	 ‐8.66	 ‐1.05	 4.860 3.805 0.260 ‐4.860 7.61	 3.100	 1.280
TPHP(Thiol)	 ‐8.59	 ‐0.61	 4.600 3.990 0.251 ‐4.600 7.98	 2.652	 1.153
MTPHP(Thione)	 ‐8.58	 ‐0.97	 4.775 3.805 0.263 ‐4.775 7.61	 2.996	 1.255
MTPHP(Thiol)	 ‐8.65	 ‐0.61	 4.630 4.020 0.249 ‐4.630 8.04	 2.666	 1.152
PTPHP(Thione)	 ‐8.58	 ‐1.13	 4.855	 3.725	 0.268	 ‐4.855	 7.45	 3.164	 1.303	
PTPHP(Thiol)	 ‐8.62	 ‐0.71	 4.665	 3.955	 0.253	 ‐4.665	 7.91	 2.751	 1.180	
[Ni(TPHP)Cl].H2O		 ‐8.42	 ‐1.41	 4.915 3.505 0.285 ‐4.915 7.01	 3.446	 1.402
[Ni(MTPHP)Cl]	 ‐8.37	 ‐1.40	 4.885	 3.485	 0.287	 ‐4.885	 6.97	 3.424	 1.402	
[Ni(PTPHP)Cl]	 ‐8.40	 ‐1.49	 4.945	 3.455	 0.289	 ‐4.945	 6.91	 3.539	 1.431	
	
	
species	 capable	 of	 accepting	 electrons	 from	 the	
environment	 and	 its	 energy	 must	 decrease	 upon	
accepting	 electronic	 charge.	 Therefore,	 the	 electronic	
chemical	 potential	 must	 be	 negative,	 exactly	 as	
supported	by	the	values	in	Table	11.	
c) The	 highest	 occupied	 molecular	 orbital	 (HOMO)	 and	
lowest	 unoccupied	molecular	 orbital	 (LUMO)	 are	 very	
popular	 quantum	 chemical	 parameters.	 These	
molecular	orbitals	are	also	called	the	frontier	molecular	
orbitals	 (FMOs)	 and	 determine	 the	way	 of	 interaction	
for	 the	 molecule	 with	 other	 species.	 The	 FMOs	 are	
important	 in	 molecular	 reactivity.	 The	 HOMO	 is	 the	
orbital	that	could	act	as	an	electron	donor,	since	it	is	the	
highest	energy	orbital	containing	electrons.	The	LUMO	
is	 the	 orbital	 that	 could	 act	 as	 the	 electron	 accepter,	
since	 it	 is	 the	 lowest	 energy	 orbital	 that	 can	 accept	
electrons.	 The	 energies	 of	 the	 HOMO	 and	 LUMO	 are	
negative,	 which	 indicate	 the	 title	 thiosemicarbazone	
molecules	are	stable	[75].	
d) Lower	 HOMO	 energy	 values	 show	 that	 the	 molecule	
donating	 electron	 ability	 is	 weaker.	 On	 contrary,	 a	
higher	 HOMO	 energy	 implies	 that	 the	 molecule	 is	 a	
good	 electron	 donor.	 The	 LUMO	 energy	 presents	 the	
ability	of	a	molecule	receiving	an	electron.	
e) From	 the	calculations	of	 the	binding	energy	we	notice	
that	 there	 is	 an	 increase	of	 the	value	of	 the	 calculated	
binding	 energy	 of	 complexes	 compared	 to	 that	 of	 the	
free	thiosemicarbazone	ligands	which	indicates	that	the	
stability	of	 the	 formed	metal	complexes	 is	higher	 than	
that	of	the	corresponding	ligands.	
	
	
Figure	4.	The	molecular	structure	of	[Ni(MTPHP)Cl]	(2)	along	with	the	atom	
numbering	scheme.	
	
3.6.	Molecular	modeling	and	biological	activity	
	
Theoretical	 calculations	 were	 performed	 in	 order	 to	
investigate	physico‐chemical	properties	that	may	be	related	to	
the	antimicrobial	 action	of	 the	studied	compounds.	Therefore,	
structure	 activity	 relationship	 (SAR)	 theoretical	 calculations	
were	 performed	 in	 order	 to	 investigate	 physico‐chemical	
properties	that	may	be	related	to	the	antimicrobial	action	of	the	
studied	 compounds.	 Properties	 of	 interest	 in	 this	 study	were	
the	 highest	 occupied	 molecular	 orbital	 (HOMO)	 and	 lowest	
unoccupied	molecular	orbital	 (LUMO)	energies	and	 the	dipole	
moments,	 which	 were	 correlated	 to	 the	 determined	 zone	 of	
inhibition	and	MIC	values.	The	HOMO	and	LUMO	energies	are	
related	 to	 ionization	 potential	 and	 electron	 affinity,	
respectively.	 These	 frontier	 orbitals	 are	 associated	 to	 the	
molecule’s	 reactivity.	 HOMO	 energy	 is	 closely	 related	 to	
reactivity	 to	electrophilic	attack	while	LUMO	energy	 is	 closely	
related	 to	 reactivity	 to	 nucleophilic	 attack.	 Additionally,	 the	
dipole	 moment	 may	 give	 some	 insight	 on	 the	 degree	 of	
hydrophobicity/hydrophilicity	 of	 the	 compounds	 i.e.	 dipole	
moment	 is	 a	 very	 useful	 parameter	 for	 determining	 the	
penetration	 through	 cell	 membrane	 and	 for	 the	 speed	 of	
excretion.	 In	 general	 HOMO	 and	 LUMO	 energies	 of	 all	
thiosemicarbazones	 were	 very	 close.	 Ni‐TPHP	 complex	 (1),	
which	presented	 the	 lowest	 value	 of	HOMO	energy	 among	 all	
Ni(II)	complexes,	showed	the	highest	biological	activity	against	
all	selected	types	of	bacteria	and	fungi.	
Additionally,	 the	dipole	moment	may	give	some	insight	on	
the	degree	of	hydrophobicity/hydrophilicity	of	the	compounds.	
SAR	 studies	 suggested	 that	 there	 is	 an	 inverse	 correlation	
between	 the	 dipole	 moment	 and	 the	 activity	 of	 the	
thiosemicarbazones	 against	 the	 studied	 bacterial	 and	 fungal	
species.	 As	 dipole	 moment	 decreases	 the	 polarity	 decreases	
and	 in	 turn	 the	 lipophilic	 nature	 of	 the	 compound	 increases,	
which	 favors	 its	permeation	more	efficiently	 through	 the	 lipid	
layer	 of	 the	 microorganism	 [76],	 thus	 destroying	 them	 more	
aggressively.	 From	 the	 data	 given	 in	 Table	 8,	 the	 dipole	
moment	 of	 Ni(II)	 complexes	 is	 lower	 than	 the	 corresponding	
free	 thiosemicarbazone	 ligands.	 Thus,	 the	 lipophilicity	 of	 the	
Ni(II)	 complexes	 is	 larger	 than	 the	 free	 thiosemicarbazone	
ligands,	 which	 in	 turn	 deactivates	 enzymes	 responsible	 for	
respiration	processes	of	the	tested	micro‐organisms	more	than	
the	 ligands	 i.e.	 the	 formation	 of	 a	 lipophilic	 complex,	 could	
enhance	 its	 penetration	 through	 the	 cytoplasmic	 membrane,	
and	consequently	increase	the	cellular	uptake	of	nickel	ions	by	
bacterial	 cells.	Consequently,	 the	 tested	complexes	were	more	
biologically	active	than	the	free	thiosemicarbazone	ligands.		
	
	
Figure	5.	The	molecular	structure	of	[Ni(PTPHP)Cl]	(3)	along	with	the	atom	
numbering	scheme.	
	
4.	Conclusions	
	
The	 condensation	 reaction	 of	 1‐(phenyl‐hydrazono)‐
propan‐2‐one	 (PHP)	 with	 thiosemicarbazide,	 N‐methylthio‐
semicarbazide	 and	 N‐phenylthiosemicarbazide	 in	 the	 molar	
ratio	 (1:1)	 afforded	 the	 corresponding	 three	 novel	
thiosemicarbazone	 compounds.	 The	 IR	 spectra	 showed	 that,	
thiosemicarbazone	 compounds	 present	 in	 the	 thione	 form	 in	
the	solid	state.	In	the	absence	of	X‐ray	single	crystal	data	of	the	
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current	 synthesized	 complexes	 and	 based	 on	 the	 physic‐
chemical	 studies	 and	 geometrical	 optimization,	 a	 tentative	
structure	 could	 be	 proposed	 as	 shown	 in	 Figures	 3‐5.	 Ni(II)‐
complexes	 are	 formulated	 as	 [NiLCl].nH2O	 where	 L	 is	 the	
deprotonated	 thiosemicarbazone	 ligand.	 In	 these	 complexes	
the	thiosemicarbazone	ligands	are	coordinated	to	the	metal	(II)	
ion	as	a	tridentate	anion,	coordinating	via	the	two	azomethine	
nitrogen	 atoms	 and	 the	 thiolate	 sulfur	 atom	 after	 deproto‐
nation.	From	elemental	analysis,	 IR,	spectral,	 thermal	analysis,	
magnetic	and	conductance	measurements,	all	Ni(II)‐complexes	
are	 nonelectrolytes	 with	 a	 square	 planar	 structure.	 Quantum	
calculations	 calculations	 prove	 also	 that	 the	 Ni(II)‐complexes	
have	square	planar	geometry.	Ni(II)‐complexes	have	nearly	the	
same	 thermal	 stability	 due	 to	 they	 are	 iso‐structural.	 In	 this	
work,	 it	 was	 found	 that	 the	 three	 compounds	 with	 different	
substituents	 show	 significantly	 different	 levels	 of	 biological	
activity.	 The	 antibacterial,	 antifungal,	 screening	 data	 revealed	
that	 newly	 generated	 compounds	 are	 potential	 antimicrobial	
agents.	 SAR	 studies	 suggested	 that	 there	 is	 an	 inverse	
correlation	between	the	dipole	moment	and	the	activity	of	the	
thiosemicarbazones	 against	 the	 studied	 bacterial	 and	 fungal	
species.	 In	 summary,	 compounds	 discussed	 in	 this	 article,	
represent	 a	 good	 model	 for	 comparison	 to	 establish	 a	 good	
correlation	of	structure	and	activity.	The	relationship	between	
structural	 and	 biological	 properties	 has	 been	 explored	 which	
could	be	helpful	in	designing	more	potent	antibacterial	agents.		
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